1-7 of 7
Wilson H. Miller, Jr., MD, PhD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Resistance To Vorinostat In Hematological Malignancies May Involve Cytoprotective UPR and Correlates With Increased Sensitivity To Bortezomib-Induced Cell Death

Daphné Dupéré-Richer, Ph.D candidate, Mena Kinal, M.Sc., Filippa Pettersson, Ph.D, Wilson H. Miller, Jr., MD, PhD
Journal: Blood
Blood (2013) 122 (21): 5137.
https://doi.org/10.1182/blood.V122.21.5137.5137
Published: 2013
Journal Articles

A New Form Of Therapeutic Resistance: Drug Glucuronidation Regulated By The Sonic Hedgehog Factor Gli1

Hiba A Zahreddine, Biljana Culjkovic-Kraljacic, PhD, Sarit Assouline, MD, Abdellatif Amri, Patrick Gendron, M.Sc., Andrea A. Romeo, PhD, Stephen Morris, PhD, James Jaquith, PhD, Gregory Cormack, Eftihia Cocolakis, PhD, Julie Bergeron, MD, Leandro Cerchietti, MD, Brian Leber, MD, Wilson H. Miller, Jr., MD, PhD, Katherine LB. Borden, PhD
Journal: Blood
Blood (2013) 122 (21): 821.
https://doi.org/10.1182/blood.V122.21.821.821
Published: 2013
Journal Articles

A Phase I Combination Study of Ribavirin and Low Dose Cytarabine Arabinoside (ara-C) in M4/M5 Acute Myeloid Leukemia (AML) and AML with High eIF4E,

Sarit Assouline, MD, Biljana Kraljacic-Culjkovic, PhD, Eftihia Cocolakis, PhD, Abdellatif Amri, Julie Bergeron, MD, Rahima Jamal, MD, Wilson H. Miller, Jr., MD, PhD, Katherine LB Borden, PhD
Journal: Blood
Blood (2011) 118 (21): 3606.
https://doi.org/10.1182/blood.V118.21.3606.3606
Published: 2011
Journal Articles

Targeting EVI1-Overexpressing AML with Darinaparsin

Koren K Mann, PhD, Nathalie Johnson, MD, Torsten Holm Nielsen, MD, Nicolas Garnier, MSc, Stanley Kwan, Eftihia Cocolakis, PhD, Josee Hebert, MD, Robert Morgan, MSc, Wilson H. Miller, Jr., MD, PhD
Journal: Blood
Blood (2011) 118 (21): 4269.
https://doi.org/10.1182/blood.V118.21.4269.4269
Published: 2011
Journal Articles

Darinaparsin a Novel Organic Arsenic Molecule Active in Lymphoma: Development of An Oral Form.

Wilson H. Miller, Jr., MD, PhD, Izidore S. Lossos, MD, PhD, Paul R. Conkling, MD, Carlos Becerra, MD, Martin S. Tallman, MD, Jill Buck, Barbara Wallner, PhD, Jonathan Lewis, MD, PhD
Journal: Blood
Blood (2009) 114 (22): 4759.
https://doi.org/10.1182/blood.V114.22.4759.4759
Published: 2009
Journal Articles

Trolox Improves the Sensitivity of Multiple Myeloma to Arsenic Trioxide in Vitro and In Vivo.

Michael Sebag, MD, PhD, Xian-Fang Huang, Nicolas Garnier, Wilson H. Miller, Jr., MD, PhD, Koren Mann, PhD
Journal: Blood
Blood (2009) 114 (22): 4920.
https://doi.org/10.1182/blood.V114.22.4920.4920
Published: 2009
Journal Articles

Targeting the Oncogene eIF4E with Ribavirin: A Novel Therapeutic Avenue in Acute Myeloid Leukemia.

Sarit E. Assouline, MD, Eftihia Cocolakis, PhD, Caroline Rousseau, PhD, Biljana Culjkovic, PhD, Nathalie Beslu, PhD, Abdellatif Amri, Stephen N. Caplan, MD, Brian Leber, MD, Denis-Claude Roy, MD, Katherine L. B. Borden, PhD, Wilson H. Miller, Jr., MD, PhD
Journal: Blood
Blood (2009) 114 (22): 2085.
https://doi.org/10.1182/blood.V114.22.2085.2085
Published: 2009